Novel immunotherapy in the management of advanced urothelial cancer - review of the literature

Novel immunotherapy in the management of advanced urothelial cancer - review of the literature

Bladder neoplasms, with the most common urothelial carcinoma, are responsible for approximately 200,000 deaths annually, which is 2.1% of the total cancer deaths in 2018. Recent decades have brought a steadily growing share of this cancer in the statistics. The 5-year survival rate is 77.1% for the...

Full description

Bibliographic Details
Main Authors: Paulina Chmiel, Martyna Kłosińska, Agnieszka Kaczyńska
Format: Article
Language:English
Published: Kazimierz Wielki University 2022-08-01
Series:Journal of Education, Health and Sport
Subjects:
bladder cancer
urothelial carcinoma
immunotherapy
checkpoints inhibitors
Online Access:https://apcz.umk.pl/JEHS/article/view/39312

Similar Items

Similar Items